Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 952-026-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- the study does not need to be conducted because skin contact in production and/or use is not likely
- the study does not need to be conducted because the substance does not meet the criteria for classification as acute toxicity or STOT SE by the oral route and no systemic effects have been observed in in vivo studies with dermal exposure (e.g. skin irritation, skin sensitisation)
- Justification for type of information:
- In accordance with column 2 of Annex VIII section 8.5.3 of REACH Regulation 1907/2006 testing by the dermal route is appropriate if 1) inhalation of the substance is unlikely, 2) skin contact in production and use is likely and 3) the physicochemical and toxicological properties suggest potential for a significant rate of absorption.
Inhalation of Synthetic wollastonite is expected to be the primary route of exposure. An acute inhalation study has been performed on the read-across material Kieselguhr soda ash flux-calcined. As Synthetic wollastonite and Kieselguhr soda ash flux-calcined follow the same exposure routes an acute dermal study was not considered to be necessary. The physiological properties of the substance do not suggest a significant rate of absorption through the skin and no systemic effects or other evidence of absorption were seen in the skin or eye irritation studies. Furthermore the test substance is poorly soluble in water and therefore a limited amount of potential substance is available for absorption via the dermal route. On this basis the short term toxicity test via the dermal route is considered to be scientifically unjustified
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- data waiving: supporting information
Reference
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 12-Apr-2010 - 26-Apr-2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed concentration procedure
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories B.V. Kreuzelweg 53 5961 NM Horst / Netherlands
- Age at study initiation: Males: 8 weeks; Females: 9 weeks
- Weight at study initiation: Males: 263.9 to 284.3 g ;Females: 182.6 to 198.0 g
- Fasting period before study:
- Housing: Animals were housed in groups of 5 of the same sex in Makrolon® type-IV cages with wire mesh tops and standard softwood bedding
- Diet: Animals had ad libitum access to a pelleted standard Harlan Teklad 2914C rat maintenance diet ( except during the period when the animalsand) batch no. were restrained in exposure tubes.
- Water: Community tap water from Füllinsdorf ad libitum in water bottles, except during the period when they were restrained in exposure tubes
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature : 22 ± 3 °C,
- Humidity: 30 - 70%
- Air changes: 10 - 15 air changes per hour
- Photoperiod 12 hour fluorescent light / 12 hour dark cycle: - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Inhalation exposure was performed using a flow-past, nose-only exposure system.
- Method of holding animals in test chamber: The animals were confined separately in restraint tubes which were positioned radially around the exposure chamber.
- Source and rate of air: The exposure system ensured a uniform distribution and provided a constant flow of test material to each exposure tube. The flow of air at each tube was 1.0 L/min.
- System of generating particulates/aerosols: A dust aerosol was generated from the test item using a CR 3020 rotating brush aerosol generator connected to a micronizing jet mill. The aerosol generated was then discharged into the exposure chamber through a 63Ni charge neutralizer
- Method of particle size determination: The particle size distribution of the test aerosol was determined three times during exposure using a 7 stage Mercer cascade Impactor (Model 02-130, In-Tox. Products Inc., Albuquerque, New Mexico, U.S.A.). The particle size distribution was measured by gravimetrically analyzing the test item deposited on each stage of the cascade impactor. Mass Median Aerodynamic Diameters (MMAD) and Geometric Standard Deviations (GSD) were calculated on the basis of the results from the impactor, using Microsoft Excel Software . The target range was 1 to 4 μm for the MMAD and between 1.5 and 3 for the GSD.
- Temperature, humidity, pressure in air chamber: The temperature and relative humidity of the test atmosphere was measured continuously during
exposure using a calibrated device. The results were recorded manually and are reported at 30 minute intervals from the start of exposure and additionally at the end of exposure The actual airflow rate through the exposure chamber was recorded at approximately 30 minute intervals from the start of the inhalation exposure.
TEST ATMOSPHERE
- Particle size distribution: Particle size distribution data are presented in table 4
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): MMAD and GSD data are presented in tables 2 and3 - Duration of exposure:
- 4 h
- Concentrations:
- The mean gravimetric aerosol concentration determined was 2.7 mg/L air
The nominal aerosol concentration was 20.4 mg/L air.
- No. of animals per sex per dose:
- 5 males and 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations for viability were recorded once before exposure on the day of exposure (test day
1), three times during exposure, immediately and 1 h after exposure on test day 1 and twice daily during the observation period. Observations for clinical signs was examined three times during exposure, immediately and 1 h after exposure on test day 1 and once daily during the observation period.The body weight of each animal was recorded on test days 1 (before exposure), 2, 4, 8 and 15 (before necropsy).
- Necropsy of survivors performed: yes - Statistics:
- No statistical analysis was performed as only one group was allocated to the study
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 2.6 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- All animals survived the scheduled observation period
- Clinical signs:
- other: Moderately ruffled fur was noted in all animals on test day 1 after the end of the exposure and persisted with a reduced severity degree until test day 2. In addition, a slightly scabbed nose was recorded in all animals on test day 1 after the end of the
- Body weight:
- From test day 1 to test day 2, marginal to slight body weight loss was noted in five males and four females. Thereafter normal body weight development was recorded in these animals. Marginal body weight loss or stagnation of the body weight gain is not unusual in inhalation studies. Therefore, effects on the body weight were considered to be mainly due to the restraining of the animals in the tubes during the nose-only exposure procedure and not related to treatment with the test item. However, a contribution of a test-item related effect cannot be excluded completely.
- Gross pathology:
- No macroscopic findings were present at necropsy
- Interpretation of results:
- not classified
- Conclusions:
- In conclusion, the LC50 of Soda-ash flux-calcined kieselguhr obtained in this study was estimated to be greater than 2.6 mg/L air (chemically determined mean aerosol concentration). As the study was conducted up to the maximum attainable concentration and in accordance with Regulation (EC) No. 1272/2008 (EU CLP) the substance is not considered to be classified.
Test atmosphere conditions:
Temperature, relative humidity and oxygen concentration during exposure were considered to be satisfactory for this type of study. Data on temperature, relative humidity and oxygen concentration are presented in table 1.
Table 1: Temperature, relative humidity and oxygen concentration
Recording time[hours:min] |
O2 concentration [Vol %] |
Temperature [°C] |
Relative humidity [% RH] |
06:30 |
20.6 |
22.2 |
9.2 |
07:00 |
20.6 |
22.3 |
5.6 |
07:30 |
20.7 |
22.4 |
5.4 |
08:00 |
20.6 |
22.3 |
5.7 |
08:30 |
20.7 |
22.3 |
5.5 |
09:00 |
20.6 |
22.3 |
5.5 |
09:30 |
20.6 |
22.4 |
7.2 |
10:00 |
20.6 |
22.3 |
5.0 |
10:30 |
20.7 |
22.3 |
5.2 |
10:39 |
20.6 |
22.3 |
5.1 |
Mean St. Dev N |
20.6 0.0 10 |
22.3 0.1 10 |
5.9 1.3 10 |
Gravimetric determination of aerosol concentrations:
The mean gravimetric aerosol concentration determined was 2.7 mg/L air. The aerosol concentration was in general stable during the exposure period. Data on gravimetric aerosol concentrations are presented in table 2.
Table 2: Gravimetric determination of aerosol concentrations
Sampling time [hours:min] |
Sampling volume [L] |
Amount of test item on the filter [mg] |
Gravimetric aerosol concentration [mg/L air] |
06:40 – 06:45 |
4.9 |
9.592 |
2.0 |
06:50 – 06:55 |
4.9 |
14.728 |
3.0 |
07:40 – 07:45 |
4.9 |
14.220 |
2.9 |
08:40 – 08:45 |
4.9 |
13.151 |
2.7 |
09:43 – 09:48 |
4.9 |
14.605 |
3.0 |
Mean St. Dev N |
|
2.7 0.4 5 |
Chemical determination of aerosol concentrations:
The chemically determined aerosol concentration was in general stable during the exposure period. Only one single value at the beginning of the aerosol generation was lower. The remainder of the values were close to the technical limit of approximately 3 mg/L as targeted. The chemical aerosol concentration compared favourably to the gravimetrically determined concentration. This was in accordance with the high purity of the test item. Details on chemically determined aerosol concentrations are presented in table 3.
Table 3: Chemical determination of aerosol concentrations
Sampling time [hours:min] |
Sampling volume [L] |
Amount of test item on the filter [mg] |
Gravimetric aerosol concentration [mg/L air] |
06:40 – 06:45 |
4.9 |
9.135 |
1.9 |
06:50 – 06:55 |
4.9 |
13.93 |
2.9 |
07:40 – 07:45 |
4.9 |
13.60 |
2.8 |
08:40 – 08:45 |
4.9 |
12.70 |
2.6 |
09:43 – 09:48 |
4.9 |
14.13 |
2.9 |
Mean St. Dev N |
|
2.6 0.4 5
|
Particle size distribution:
The Mass Median Aerodynamic Diameters (MMAD) obtained from tree gravimetric measurements of particle size distribution during the exposure were similar (MMAD between 2.39 and 2.95 μm). This led to the conclusion that the particle size of the generated aerosol was fairly stable during the whole exposure period. The MMADs were well within the target range of 1 to 4 μm, thus deposition of the particles can be assumed to have occurred in both the upper and the lower respiratory tract. In addition, the Geometric Standard Deviations (GSD) were within the target range of 1.5 to 3. Hence, the particle size distributions obtained were considered to be appropriate for acute inhalation toxicity testing. Data on particle size distribution are presented in table 4.
Table 4: Particle size distribution
Time |
Total amount collected [µg] |
|
MMAD [µm] |
GSD |
Corr.Coeff (R ) |
% < 4 µm |
|||||||
1 -- |
2 4.6 |
3 3.0 |
4 2.13 |
5 1.6 |
6 1.06 |
7 0.715 |
8 0.325 |
||||||
06:58 |
1487 |
19.4 |
30.3 |
16.6 |
13.4 |
9.8 |
7.5 |
0.8 |
2.2 |
2.75 |
2.32 |
0.964 |
67.2 |
07:42 |
1919 |
23.4 |
27.6 |
16.1 |
16.3 |
7.7 |
4.7 |
1.4 |
2.9 |
2.95 |
2.47 |
0.957 |
63.2 |
08:42 |
828 |
13.9 |
32.7 |
16.5 |
11.6 |
6.6 |
12.6 |
3.7 |
2.3 |
2.39 |
2.35 |
0.973 |
72.8 |
- Reason / purpose for cross-reference:
- data waiving: supporting information
Reference
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- The study was performed between 01 June 2010 and 24 June 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories UK Ltd, Bicester, Oxon, UK
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: 15 to 23 g
- Housing: Individually housed in suspended solid-floor polypropylene cages furnished with softwood woodflakes
- Diet: 2014 Tekland Global Rodent diet ad libitum
- Water: ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature: 19 to 25°C
- Humidity: 30 - 70 %
- Air changes: Approximately 15 per hr
- Photoperiod: 12 hrs dark / 12 hrs light - Vehicle:
- propylene glycol
- Concentration:
- Groups of four mice were treated with the test material at concentrations of 10%, 5% or 2.5% w/w in propylene glycol
- No. of animals per dose:
- 4 mice per dose
- Details on study design:
- PRELIMINARY SCREENING TEST:
Using available information regarding the systemic toxicity/irritancy potential of the test material, a preliminary screening test was performed using one mouse. The mouse was treated by daily application of 25 µl of the test material at a concentration of 10% w/w in propylene glycol, to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The mouse was observed twice daily on Days 1, 2 and 3 and once daily on Days 4, 5 and 6. Any signs of toxicity or excessive local irritation noted during this period were recorded. The bodyweight was recorded on Day 1 (prior to dosing) and on Day 6
MAIN STUDY:
Groups of four mice were treated with the test material at concentrations of 10%, 5% or 2.5% w/w in propylene glycol. The preliminary screening test suggested that the test material would not produce systemic toxicity or excessive local irritation at the highest suitable concentration. The mice were treated by daily application of 25 µl of the appropriate concentration of the test material to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The test material formulation was administered using an automatic micropipette and spread over the dorsal surface of the ear using the tip of the pipette.
A further group of four mice received the vehicle alone in the same manner.
3H-Methyl Thymidine Administration
Five days following the first topical application of the test material or vehicle (Day 6) all mice were injected via the tail vein with 250 µl of phosphate buffered saline (PBS) containing 3H methyl thymidine (3HTdR: 80 µCi/ml, specific activity 2.0 Ci/mmol, ARC UK Ltd) giving a total of 20 µCi to each mouse - Positive control substance(s):
- other: Phenylacetaldehyde (90%)
- Positive control results:
- A group of five animals was treated with 50 µl (25 µl per ear) of Phenylacetaldehyde (90%) as a solution in propylene glycol at a concentration of 2.5% v/v. A further control group of five animals was treated with propylene glycol alone
The Stimulation Index expressed as the mean radioactive incorporation for the treatment group divided by the mean radioactive incorporation of the vehicle control group was 18.43.
Phenylacetaldehyde (90%) was considered to be a sensitiser under the conditions of the test - Key result
- Parameter:
- SI
- Value:
- 1.13
- Test group / Remarks:
- 4 animals: 2.5 % in propylene glycol
- Key result
- Parameter:
- SI
- Value:
- 0.97
- Test group / Remarks:
- 4 animals: 5 % in propylene glycol
- Key result
- Parameter:
- SI
- Value:
- 0.99
- Test group / Remarks:
- 4 animals: 10 % in propylene glycol
- Interpretation of results:
- not sensitising
- Conclusions:
- Kieselguhr soda ash flux calcined is not classified as a skin sensitiser in accordance with CLP Regulation (EC) no. 1272/2008
Table 1: Clinical Observations, Bodyweight and Mortality Data – Preliminary Screening Test
Concentration (%w/w) in |
Animal Number |
Bodyweight (g) |
Day |
|||||||||
1 |
2 |
3 |
4 |
5 |
6 |
|||||||
Day 1 |
Day 6 |
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
|||||
10 |
S-1 |
19 |
20 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0= No signs of systemic toxicity
Table 2: Disintegrations per Minute, Disintegrations per Minute/Node and Stimulation Index
Concentration |
dpm |
dpm/Nodea |
Stimulation Indexb |
Result |
Vehicle |
6210.33 |
776.29 |
na |
na |
2.5 |
7020.81 |
877.60 |
1.13 |
Negative |
5 |
6047.51 |
755.94 |
0.97 |
Negative |
10 |
6135.29 |
766.91 |
0.99 |
Negative |
dpm= Disintegrations per minute
a= Disintegrations per minute/node obtained by dividing the disintegrations per minute value by 8 (total number of lymph nodes)
b= Stimulation Index of 3.0 or greater indicates a positive result
na = Not applicable
Table 3: Individual Clinical Observations and Mortality Data
Concentration |
Animal Number |
Day 1 |
Day 2 |
Day 3 |
Day 4 |
Day 5 |
Day 6 |
|||
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
|||||
Vehicle |
1-1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1-2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
1-3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
1-4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
2.5 |
2-1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2-2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
2-3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
2-4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
5 |
3-1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3-2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
3-3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
3-4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
10 |
4-1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4-2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
4-3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
4-4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0= No signs of systemic toxicity
Table 4: Individual Bodyweights and Bodyweight Changes
Concentration |
Animal Number |
Bodyweight (g) |
Bodyweight Change (g) |
|
Day 1 |
Day 6 |
|||
Vehicle |
1-1 |
20 |
20 |
0 |
1-2 |
20 |
21 |
1 |
|
1-3 |
17 |
17 |
0 |
|
1-4 |
18 |
17 |
-1 |
|
2.5 |
2-1 |
18 |
17 |
-1 |
2-2 |
19 |
19 |
0 |
|
2-3 |
19 |
19 |
0 |
|
2-4 |
19 |
19 |
0 |
|
5 |
3-1 |
20 |
20 |
0 |
3-2 |
20 |
19 |
-1 |
|
3-3 |
18 |
18 |
0 |
|
3-4 |
20 |
20 |
0 |
|
10 |
4-1 |
17 |
17 |
0 |
4-2 |
21 |
20 |
-1 |
|
4-3 |
18 |
18 |
0 |
|
4-4 |
20 |
20 |
0 |
Data source
Materials and methods
Results and discussion
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.